We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Tilray Brands Inc | NASDAQ:TLRY | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.56% | 1.78 | 1.78 | 1.79 | 41,944 | 11:19:42 |
March 4, 2020 -- InvestorsHub NewsWire -- via Jose Rodrigo , Benzinga Staff Writer
March 03, 2020
Puration Inc PURA and Kali-Extracts KALY said Monday that a planned acquisition by Pura of Kaly's CBD confections operations is underway.
Kaly is focusing its business on cannabis extract biopharmaceuticals, and its leading research has been on the treatment of respiratory conditions, the companies said.
Kaly has filed a new patent application on its CBD formulation for the symptoms of COPD and similar respiratory conditions, the companies said. The company has also filed for a trademark on the name RespRx as a brand of CBD for COPD symptoms and other conditions that cause respiratory inflammation.
The company said it is evaluating its proprietary CBD extract formulation as a treatment for symptoms of coronavirus.
See other recent BENZINGA articles on cannabis sector compaines including James E. Wagner Cultivation Corporation (OTC:JWCAF), and Tilray, Inc. (TLRY).
SOURCE: Jose Rodrigo, Benzinga Staff Writer
1 Year Tilray Brands Chart |
1 Month Tilray Brands Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
